240 related articles for article (PubMed ID: 23920220)
1. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.
Wu W; Jamshidi N; Eraly SA; Liu HC; Bush KT; Palsson BO; Nigam SK
Drug Metab Dispos; 2013 Oct; 41(10):1825-34. PubMed ID: 23920220
[TBL] [Abstract][Full Text] [Related]
2. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
Nigam AK; Li JG; Lall K; Shi D; Bush KT; Bhatnagar V; Abagyan R; Nigam SK
J Biol Chem; 2020 Feb; 295(7):1829-1842. PubMed ID: 31896576
[TBL] [Abstract][Full Text] [Related]
3. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
Bush KT; Wu W; Lun C; Nigam SK
J Biol Chem; 2017 Sep; 292(38):15789-15803. PubMed ID: 28765282
[TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
Granados JC; Richelle A; Gutierrez JM; Zhang P; Zhang X; Bhatnagar V; Lewis NE; Nigam SK
J Biol Chem; 2021; 296():100575. PubMed ID: 33757768
[TBL] [Abstract][Full Text] [Related]
5. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
Nagle MA; Wu W; Eraly SA; Nigam SK
Neurosci Lett; 2013 Feb; 534():133-8. PubMed ID: 23196129
[TBL] [Abstract][Full Text] [Related]
6. Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.
Nagle MA; Truong DM; Dnyanmote AV; Ahn SY; Eraly SA; Wu W; Nigam SK
J Biol Chem; 2011 Jan; 286(1):243-51. PubMed ID: 20921221
[TBL] [Abstract][Full Text] [Related]
7. Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys.
Breljak D; Brzica H; Sweet DH; Anzai N; Sabolic I
Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1114-26. PubMed ID: 23389457
[TBL] [Abstract][Full Text] [Related]
8. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.
Nigam SK; Wu W; Bush KT; Hoenig MP; Blantz RC; Bhatnagar V
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2039-49. PubMed ID: 26490509
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.
Martovetsky G; Tee JB; Nigam SK
Mol Pharmacol; 2013 Dec; 84(6):808-23. PubMed ID: 24038112
[TBL] [Abstract][Full Text] [Related]
10. Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.
Jamshidi N; Nigam SK
Sci Rep; 2022 Oct; 12(1):18308. PubMed ID: 36316339
[TBL] [Abstract][Full Text] [Related]
11. Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin.
Vanwert AL; Srimaroeng C; Sweet DH
Mol Pharmacol; 2008 Jul; 74(1):122-31. PubMed ID: 18381565
[TBL] [Abstract][Full Text] [Related]
12. The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.
Nigam SK
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():663-687. PubMed ID: 29309257
[TBL] [Abstract][Full Text] [Related]
13. Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
Truong DM; Kaler G; Khandelwal A; Swaan PW; Nigam SK
J Biol Chem; 2008 Mar; 283(13):8654-63. PubMed ID: 18174163
[TBL] [Abstract][Full Text] [Related]
14. Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics.
Vallon V; Rieg T; Ahn SY; Wu W; Eraly SA; Nigam SK
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F867-73. PubMed ID: 18216144
[TBL] [Abstract][Full Text] [Related]
15. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.
Granados JC; Bhatnagar V; Nigam SK
Clin Pharmacol Ther; 2022 Sep; 112(3):653-664. PubMed ID: 35490380
[TBL] [Abstract][Full Text] [Related]
17. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
Bush KT; Singh P; Nigam SK
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
[TBL] [Abstract][Full Text] [Related]
18. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
Wu W; Bush KT; Nigam SK
Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
[TBL] [Abstract][Full Text] [Related]
19. Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G.
Vanwert AL; Bailey RM; Sweet DH
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1332-41. PubMed ID: 17686950
[TBL] [Abstract][Full Text] [Related]
20. The organic anion transporter (OAT) family: a systems biology perspective.
Nigam SK; Bush KT; Martovetsky G; Ahn SY; Liu HC; Richard E; Bhatnagar V; Wu W
Physiol Rev; 2015 Jan; 95(1):83-123. PubMed ID: 25540139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
